Nea Management Company, LLC Lumos Pharma, Inc. Transaction History

Nea Management Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.68 - $9.39 $682,923 - $959,977	-102,234 Reduced 61.0%	65,374 $503,000
Q1 2022 May 16, 2022	SELL	$6.58 - $10.09 $1.38 Million - $2.11 Million	-209,308 Reduced 55.53%	167,608 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$6.84 - $10.04 $1.02 Million - $1.5 Million	-149,747 Reduced 28.43%	376,916 $2.61 Million
Q1 2020 May 06, 2020	BUY	$0.89 - $8.85 $468,730 - $4.66 Million	526,663 New	526,663 $4.48 Million

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.